Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World.
Saved in:
| Title: | Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World. |
|---|---|
| Authors: | de Gea-Grela A; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain., Micán R; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., de Miguel R; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Serrano L; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain., Marcelo C; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain., Montes ML; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Ramos-Ruperto L; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain., Busca C; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Arcos-Rueda MDM; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain., Montejano R; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Arribas JR; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Gonzalez-García J; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Bernardino JI; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Martín-Carbonero L; HIV Unit, Internal Medicine Department, La Paz-Carlos III University Hospital, IdiPaz, Madrid, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. |
| Source: | Open forum infectious diseases [Open Forum Infect Dis] 2025 Feb 27; Vol. 12 (3), pp. ofaf087. Date of Electronic Publication: 2025 Feb 27 (Print Publication: 2025). |
| Publication Type: | Clinical Trial; Journal Article |
| Journal Info: | Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2328-8957 |
|---|---|
| DOI: | 10.1093/ofid/ofaf087 |
